CSIMarket
 

Zimvie Inc   (NASDAQ: ZIMV)

Zimvie Inc 's

Competitiveness




 

ZIMV Sales vs. its Competitors Q2 2025



Comparing the current results to its competitors, Zimvie Inc reported Revenue decrease in the 2 quarter 2025 year on year by -0.13 %, despite the revenue increase by the most of its competitors of 9.24 %, recorded in the same quarter.

List of ZIMV Competitors





Revenue Growth Comparisons




Net Income Comparison


Zimvie Inc , despite income growth by most of its competitors recorded a net loss, despite income increase by most of its competitors of 14.8 %

<<  ZIMV Stock Performance Comparisons


Zimvie Inc 's Comment on Competition and Industry Peers


The company maintains its competitive position through trade secrets, know-how, technological innovation, and licensing opportunities. It protects proprietary rights via confidentiality and proprietary information agreements with suppliers, employees, consultants, and others. The company owns or controls over 400 issued patents and patent applications worldwide. No individual patent, trademark, copyright, trade secret, or license is considered materially important to any segment or the overall business.



  

Overall company Market Share Q2 2025

Overall company, revenue fell by -0.13 % and company lost market share, to approximately 0.22 %.




<<  More on ZIMV Market Share.
 
*Market share is calculated based on total revenue.

  News about Zimvie Inc Contracts

ZimVie Inc. Achieves FDA Clearance for Vital Spinal Fixation System and Brainlab Collaboration, Aims to Bolster Revenue Growth.

December 12, 2023
ZimVie Inc. Receives FDA Clearance for Spinal Fixation System Compatibility with Brainlab Spine and Trauma Navigation
ZimVie Inc., a renowned global leader in the dental and spine markets, has recently announced significant progress in its pursuit of innovative solutions for the spinal fixation industry. In a recent press release, the company revealed that it had received FDA clearance for its Vital Spinal Fixation System, including instruments used in conjunction with Brainlab s Spine and Trauma Navigation.
This achievement marks a major milestone in ZimVie s development cooperation efforts with Brainlab, which were initiated in March 2023. The primary objective of this collaboration was to establi...





Publicly Traded Peers of Zimvie Inc




Jin Medical International Ltd
Share Performance



-84.00%
One Year



Jin Medical International Ltd
Profile

Jin Medical International Ltd. operates in the medical technology sector in China through a variable interest entity (VIE).

More about Jin Medical International Ltd's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 327.183 mill. $ 20.687 mill. $ 1.381 mill.


Encision Inc
Share Performance



+20,200.00%
This Quarter



Encision Inc
Profile

Encision Inc is a medical device company that designs, develops, manufactures, and markets surgical products utilizing its patented active electrode monitoring technology for precision in minimally invasive surgeries, thereby providing increased patient safety and reduced overall healthcare costs. Their business model centers around creating and selling innovative surgical devices that incorporate their unique technology to improve surgical outcomes and enhance safety in the medical field.

More about Encision Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 0.576 mill. $ 6.300 mill. $ -0.381 mill.


Conmed Corporation
Share Performance



+13.83%
This Year



Conmed Corporation
Profile

Conmed Corporation operates as a global medical technology company that develops, manufactures, and markets surgical devices and equipment for minimally invasive procedures.

More about Conmed Corporation's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 1,389.147 mill. $ 1,371.657 mill. $ 56.497 mill.


Bioventus Inc
Share Performance



+58.62%
This Quarter



Bioventus Inc
Profile

Bioventus Inc is a medical technology company that focuses on developing and commercializing orthobiologic solutions for musculoskeletal conditions. They offer a range of products and services, including orthobiologics, braces, and devices, aimed at improving patient outcomes and quality of life.

More about Bioventus Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 977.571 mill. $ 581.106 mill. $ 61.475 mill.


Biolase Inc
Share Performance



-70.15%
30 Days



Biolase Inc
Profile

Biolase Inc's business model revolves around developing and manufacturing dental laser systems and related products.

More about Biolase Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 0.628 mill. $ 43.720 mill. $ -32.953 mill.

30 more competitors available

Sign in to see all competitors

Sources: Zimvie Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Zimvie Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.